nQ Rx - Digital Biomarkers
nQ’s digital biomarkers can be deployed in a specialized role: Software as a Medical Device (SaMD) analyzes smartphone and keyboard typing patterns using compressed temporal typing data assisted by machine learning to identify abnormalities in cognition and fine motor function in adults with neurodegenerative diseases.
nQ Rx can characterize these subsets of psychomotor function into a more objective and granular manner than current gold standard assessment tools. Physicians and patients can now have access to continuous real world evidence generated from functional, real-world data.
nQ is working to deliver prescription digital biomarkers across a broad range of neurodegenerative diseases in support of early detection, remote patient monitoring, and improved treatment pathways. We aim to bring accurate, affordable accessible digital tools to patients everywhere.